The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
New Board of Directors and management team at Suven Pharma also appointed
Subscribe To Our Newsletter & Stay Updated
